Depository of News

Two Bundibugyo‑Targeted Ebola Vaccines to Begin Phase‑2 Trials in DRC

kenya-today.com · health

Oxford‑Moderna and Oxford‑Serum Institute candidates will start Phase‑2 testing in Bunia next week, marking a key step against the Bundibugyo Ebola strain.

Read full article →